USPTO Rejects Benitec Patent Claims After Initial Review, Company to File Response

The decision is the latest setback for Benitec in an ongoing legal battle between Benitec and rival Nucelonics that began last April when Benitec sued the company for allegedly infringing a key RNAi patent. Subscribers: click headline for more

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.